Literature DB >> 10700886

[Standard chemotherapy for gastrointestinal malignancies based on evidence].

T Sasaki1, Y Maeda, T Kobayashi, R Okamoto, Y Omuro, N Takada.   

Abstract

It has been said that there is no standard chemotherapy for gastrointestinal malignancies. However, standard guidelines are essential to increase the level of medical treatment, and the death rate from gastrointestinal malignancies is very high in Japan. FAMTX, standard therapy for gastric cancer abroad, cannot be standard in Japan due to its toxicities. A combination of 5-FU and cisplatin (FP) is most commonly used as the the first choice for chemotherapy, but it's regimens vary. For colon cancer, it is said that a combination of 5-FU and Leucovorin (LV) is standard, but CPT-11, made in Japan, is a promising agent. There is no recommended drug for advanced pancreatic cancer, so palliative care or no chemotherapy are also available alternatives.

Entities:  

Mesh:

Year:  2000        PMID: 10700886

Source DB:  PubMed          Journal:  Gan To Kagaku Ryoho        ISSN: 0385-0684


  1 in total

1.  Docetaxel and cisplatin in patients with advanced gastric cancer: results of Japanese phase I/II study.

Authors:  Soh Saitoh; Yuh Sakata
Journal:  Gastric Cancer       Date:  2002       Impact factor: 7.370

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.